Prospective randomized controlled study on the effect of Theranova on quality-of-life outcomes in maintenance dialysis patients
Not Applicable
Completed
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0003026
- Lead Sponsor
- Kyungpook National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1) Dialysis treatment more than 3 months
2) Hemodialysis with high-flux dialysis membrane
3) Vascular access for dilaysis via AVF or AVG
4) Adequate dialysis (KT/V >1.2)
5) Age 18 years or older
6) Voluntary enrolled and can answer the questionnaire
Exclusion Criteria
1) Hemodialysis with low-flux dialysis membrane
2) Vascular access for dilaysis via temporary catheter
3) Scheduled KT or admission within 3 months
4) Hematologic malignancy or monoclonal gammopathy
5) Solid organ malignancy
6) Active infection
7) HIV infection
8) Enrolled other clinical trials within 3 months
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life questionnaire, pruritis score
- Secondary Outcome Measures
Name Time Method Beta2 microglobulin, complement factor D, homocystein, leptin, hepcidin, erythroferrone, interleukin-6, YKL-40;Hemoglobin level, dosage requirement of erythropoiesis stimulating agents, dosage requirement of iron agent, blood pressure